Clinical trials
Completed Cystic Fibrosis trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
156 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 8 |
| 2009 | 12 |
| 2010 | 7 |
| 2011 | 6 |
| 2012 | 12 |
| 2013 | 8 |
| 2014 | 11 |
| 2015 | 16 |
| 2016 | 11 |
| 2017 | 14 |
| 2018 | 10 |
| 2019 | 13 |
| 2020 | 5 |
| 2021 | 10 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 156 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vertex Pharmaceuticals Incorporated | 28 |
| Assistance Publique - Hôpitaux de Paris | 25 |
| Hospices Civils de Lyon | 14 |
| University Hospital, Montpellier | 10 |
| University Hospital, Strasbourg, France | 6 |
| Nantes University Hospital | 4 |
| PTC Therapeutics | 4 |
| University Hospital, Brest | 4 |
| University Hospital, Tours | 4 |
| Boehringer Ingelheim | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cystic Fibrosis | 156 |
| Lung Diseases | 7 |
| Pseudomonas Infections | 6 |
| Respiratory Tract Infections | 4 |
| Anxiety Disorders | 3 |
| Fibrosis | 3 |
| Genetic Diseases, Inborn | 3 |
| Pancreatic Diseases | 3 |
| Pathologic Processes | 3 |
| Respiratory Tract Diseases | 3 |
Trials
Showing 1 to 25 of 156. Each trial links to its page on Pharma Observatory.
56 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.